Huatai-PB CNI Vaccines and biotechnology ETF (159646.SZ) Latest Stock News - Major News Analysis - Longbridge

For Institutions
- Corporate Services
- Developers
Download
Help
About

Markets

Information

Affiliate Program

Promotions

EN

English

简体中文

繁體中文

繁體中文（廣東話）Posts & comments will be shown in Cantonese

Search...

Quote List Quote List

© 2025 Longbridge｜Disclaimer

Event Tracking

Dec28

Huahai Pharmaceutical and Shanghai Huahai's SHR-A1904 Injection Listed as Breakthrough Therapy

10:24

Hengrui Medicine Subsidiary Entrusts Hansoh Pharmaceutical for Palocabigine Soft Capsule Commercialization

08:39

Dec24

Lizhu Pharmaceutical and XinKangHe BioMed's Lekangqita Injection Receives NMPA Marketing Authorization Application Acceptance

09:36

Hengrui Medicine’s SHR-A1904 Injection Included in Breakthrough Therapy List

08:56

Hengrui Medicine Subsidiary's SHR-A2102 Receives Clinical Trial Approval from NMPA

08:47

Dec23

Fosun Pharma Aims to Acquire 75% Equity of Green Valley Pharmaceutical for 1.412 Billion Yuan

19:12